These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3542449)
1. Overnight interruption of wearing insulin pump: substitution dose and injection site of insulin. Helve E; Pelkonen R; Koivisto VA Diabetes Care; 1986; 9(6):565-9. PubMed ID: 3542449 [TBL] [Abstract][Full Text] [Related]
2. Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII. Scheen AJ; Henrivaux P; Jandrain B; Paolisso G; Lefèbvre PJ Diabetes Care; 1987; 10(5):567-72. PubMed ID: 3315513 [TBL] [Abstract][Full Text] [Related]
3. Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion. Olsson PO; Arnqvist H; Von Schenck H; Ottosson AM Diabetes Care; 1987; 10(6):702-6. PubMed ID: 3322726 [TBL] [Abstract][Full Text] [Related]
4. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Attia N; Jones TW; Holcombe J; Tamborlane WV Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247 [TBL] [Abstract][Full Text] [Related]
5. Early morning glycaemia and the metabolic consequences of delaying breakfast/morning insulin. A comparison of continuous subcutaneous insulin infusion and multiple injection therapy with human isophane or human ultralente insulin at bedtime in insulin-dependent diabetics. Haakens K; Hanssen KF; Dahl-Jørgensen K; Vaaler S; Torjesen P; Try K Scand J Clin Lab Invest; 1989 Nov; 49(7):653-9. PubMed ID: 2692136 [TBL] [Abstract][Full Text] [Related]
6. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump. Catargi B; Breilh D; Roger P; Tabarin A Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895 [TBL] [Abstract][Full Text] [Related]
7. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM. Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173 [TBL] [Abstract][Full Text] [Related]
8. Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Scheen A; Castillo M; Jandrain B; Krzentowski G; Henrivaux P; Luyckx AS; Lefèbvre PJ Diabetes Care; 1984; 7(4):338-42. PubMed ID: 6381007 [TBL] [Abstract][Full Text] [Related]
9. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors. Hildebrandt P Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533 [TBL] [Abstract][Full Text] [Related]
10. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects. Bantle JP; Neal L; Frankamp LM Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455 [TBL] [Abstract][Full Text] [Related]
11. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies. Olsson PO Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting. Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes. Alemzadeh R; Parton EA; Holzum MK Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060 [TBL] [Abstract][Full Text] [Related]
14. U-100 insulin gives some protection against metabolic deterioration due to CSII interruption. Scheen AJ; Henrivaux P; Jandrain B; Lefèbvre PJ Diabetes Care; 1987; 10(6):707-11. PubMed ID: 3322727 [TBL] [Abstract][Full Text] [Related]
15. Postprandial blood glucose response to exercise in type I diabetes: comparison between pump and injection therapy. Koivisto VA; Tronier B Diabetes Care; 1983; 6(5):436-40. PubMed ID: 6400702 [TBL] [Abstract][Full Text] [Related]
16. Short-term subcutaneous insulin infusion in diabetic children. Comparison with three daily insulin injections. Meschi F; Beccaria L; Vanini R; Szulc M; Chiumello G Acta Diabetol Lat; 1982; 19(4):371-5. PubMed ID: 6758461 [TBL] [Abstract][Full Text] [Related]
17. [Nocturnal continuous subcutaneous insulin infusion--a therapeutic possibility in labile type I diabetes under exceptional conditions]. Bruns W; Steinborn F; Menzel R; Staritz B; Bibergeil H Z Gesamte Inn Med; 1990 Mar; 45(6):154-8. PubMed ID: 2197828 [TBL] [Abstract][Full Text] [Related]
18. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727 [TBL] [Abstract][Full Text] [Related]